See also this year's filing and all EDGAR filings for this company.
PDF Report 0001659617_2026_Moleculin_Biotech_Inc.pdf
Logs
Graph
Absolute values for 0001659617, Moleculin Biotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,686,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 78,000 |
| 3 | remainder_Assets | 12,362,000 |
| 4 | LiabilitiesCurrent | 6,854,000 |
| 5 | LiabilitiesNoncurrent | 222,000 |
| 6 | remainder_Liabilities | 44,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,672,790 |
| 9 | ResearchAndDevelopmentExpense | 10,379,865 |
| 10 | remainder_Expenses | -17,535,604 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -21,929,013 |
| 13 | remainder_ComprehensiveNetIncome | 20,506 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 22,126,000 |
| 1 | Liabilities | 7,120,000 |
| 2 | Expenses | 1,517,051 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 15,006,000 |
| 5 | NetIncome | -23,446,064 |
| 6 | ComprehensiveNetIncome | -23,435,811 |
| 7 | BaseVar | 26,356,285 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.634 |
| 9 | EconomicCapitalRatio | 2.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
